相关实验视频
Updated: Jun 10, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
针对CBP和p300:新兴的抗癌剂
Domiziana Masci1, Michela Puxeddu2, Romano Silvestri2
1Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.
Molecules (Basel, Switzerland)
|October 16, 2024
概括
研究人员正在开发小分子来抑制CBP和p300联合激活剂,这对于Wnt/β-catenin信号传递至关重要,以治疗由这种途径驱动的癌症.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 药物发现 药物发现 药物发现
背景情况:
- CBP和p300是关键的转录性联合激活剂,调节重要的细胞过程和信号通路,如Wnt/β-catenin.
- 失调的Wnt/β-catenin信号传递与各种癌症有关,导致瘤扩散,迁移和入侵.
- 针对β-catenin和CBP/p300之间的相互作用,为癌症治疗提供了一个有希望的策略.
研究的目的:
- 审查最近 (2010年至今) 开发针对CBP/β-catenin和p300/β-catenin相互作用的小分子抑制剂的进展.
- 探索CBP/p300代蛋白和基酸转移酶抑制剂在癌症治疗中的治疗潜力.
- 提供针对Wnt/β-catenin驱动瘤发生的CBP和p300的策略的概述.
主要方法:
- 在PubMed文献中搜索2010年至今的原始研究文章.
- 专注于研究开发CBP/β-catenin和p300/β-catenin相互作用的特异性和非特异性抑制剂.
- 包括CBP/p300代蛋白和基酸转移酶抑制剂的研究.
主要成果:
- 在识别抑制CBP/β-catenin和p300/β-catenin相互作用的小分子方面取得了重大进展.
- 各种CBP/p300抑制剂通过破坏瘤原体信号通路来显示治疗潜力.
- 研究强调了这些协同激活剂在Wnt/β-catenin驱动癌症中的作用.
结论:
- 针对CBP和p300与β-catenin的相互作用,为Wnt/β-catenin驱动的癌症提供了一种可行的治疗方法.
- CBP/p300 抑制剂,包括代和HAT 抑制剂,是新型癌症治疗的有希望的途径.
- 对这些向治疗的进一步研究对于有效的癌症干预至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K

